Computational Studies in Nanoparticles


The computational studies in nanoparticles have demonstrated that there has been considerable progress in Nano and biotechnology in the last several years. However, several key challenges have also become apparent, including the need for a better understanding of nanoparticle behaviour in vivo and the development of more effective nanoparticle therapeutics. Computational efforts are becoming an important tool in addressing both of these challenges, as well as in generally facilitating and accelerating nanotechnology-based translational research. The Nanoinformatics has come out as a new research area that covers raw data management, analysis of the data derived from biomedical applications and simulation of nanoparticle interactions with biological systems depicting the integration of biology, nanotechnology and informatics to form the basis for computational Nanomedicine.



 

    Related Conference of Computational Studies in Nanoparticles

    December 05-06, 2022

    Applied Nanotechnology Summit

    Paris, France
    January 18-19, 2023

    Global Summit on Nanoscience and Technology

    Vancouver, Canada
    January 18-19, 2023

    3rd World Conference on Aerospace Engineering

    London, UK
    April 17-18, 2023

    35th Nano Congress for Future Advancements

    Paris, France
    May 10-11, 2023

    8th Annual Conference and Expo on Biomaterials

    Zurich, Switzerland
    June 26-27, 2023

    40th Global Summit on Nanoscience and Technology

    Tokyo, Japan
    July 05-06, 2023

    40th Global Nanotechnology Congress

    Paris, France
    August 08-09, 2023

    26th World Nanotechnology Congress

    Dublin, Ireland
    September 27-28, 2023

    32nd International Conference on Nanomedicine & Drug Delivery

    Zurich, Switzerland
    November 08-09, 2023

    4th World Congress on Nanotechnology and Advanced Materials

    Budapest, Hungary

    Computational Studies in Nanoparticles Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in